Literature DB >> 25465242

Pathogenesis of Breast Cancer Metastasis to Brain: a Comprehensive Approach to the Signaling Network.

Bahrami Tayyeb1, Mehdipour Parvin2.   

Abstract

There is a general consensus that breast cancer is a rising trend disease in the world. It is one of the most common cancer types and is the leading cause of death among women's cancers. There are several reasons for this high rate of mortality including metastasis which is responsible for about 90 % of cancer-related mortality. Therefore, recognition and understanding of metastatic process is important, and by considering the key role of pathophysiological route in metastasis as a multistep cascade of "invasion-metastasis," it might modify and improve our insight toward this complex phenomenon. Moreover, it can provide novel approaches for designing advanced targeted therapies. The present work aimed to review the published papers regarding molecular basis of metastatic process of breast cancer to brain metastasis, especially related genes and signaling network. Furthermore, the use of molecular aspects of metastatic breast cancer to brain was discussed in horizon of future treatment of breast cancer.

Entities:  

Keywords:  Brain metastasis; Breast cancer; Gene; Signaling pathways

Mesh:

Year:  2014        PMID: 25465242     DOI: 10.1007/s12035-014-9023-z

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  102 in total

1.  SnapShot: directed differentiation of pluripotent stem cells.

Authors:  Luis A Williams; Brandi N Davis-Dusenbery; Kevin C Eggan
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

Review 2.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

3.  ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis.

Authors:  Thomas Worzfeld; Jakub M Swiercz; Mario Looso; Beate K Straub; Kishor K Sivaraj; Stefan Offermanns
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

4.  MMP-9 increases HER2/neu expression and alters apoptosis levels in human mammary epithelial cells (HMEC).

Authors:  Matilda Fatunmbi; Justin Shelton; Susan M Aronica
Journal:  Breast Cancer Res Treat       Date:  2012-08-10       Impact factor: 4.872

5.  Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).

Authors:  B C Pestalozzi; D Zahrieh; K N Price; S B Holmberg; J Lindtner; J Collins; D Crivellari; M F Fey; E Murray; O Pagani; E Simoncini; M Castiglione-Gertsch; R D Gelber; A S Coates; A Goldhirsch
Journal:  Ann Oncol       Date:  2006-04-07       Impact factor: 32.976

Review 6.  Molecular networks that regulate cancer metastasis.

Authors:  Daniela Spano; Chantal Heck; Pasqualino De Antonellis; Gerhard Christofori; Massimo Zollo
Journal:  Semin Cancer Biol       Date:  2012-03-30       Impact factor: 15.707

7.  Plasma levels of matrix metalloproteinases 2 and 9 correlate with histological grade in breast cancer patients.

Authors:  Fortunata Vasaturo; Fabiana Solai; Carolina Malacrino; Tiziana Nardo; Bruno Vincenzi; Mauro Modesti; Susanna Scarpa
Journal:  Oncol Lett       Date:  2012-10-17       Impact factor: 2.967

Review 8.  CNS metastasis: an old problem in a new guise.

Authors:  Jeanny B Aragon-Ching; Jo Anne Zujewski
Journal:  Clin Cancer Res       Date:  2007-03-15       Impact factor: 12.531

9.  Risk factors for central nervous system metastasis in patients with metastatic breast cancer.

Authors:  Canfeza Sezgin; Erhan Gokmen; Mustafa Esassolak; Necmettin Ozdemir; Erdem Goker
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

10.  HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma.

Authors:  Tieju Liu; Baocun Sun; Xiulan Zhao; Qiang Gu; Xueyi Dong; Zhi Yao; Nan Zhao; Jiadong Chi; Ning Liu; Ran Sun; Yuemei Ma
Journal:  J Cell Mol Med       Date:  2012-12-19       Impact factor: 5.310

View more
  5 in total

Review 1.  Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon?

Authors:  Jiri Polivka; Milena Kralickova; Jiri Polivka; Christina Kaiser; Walther Kuhn; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-03-13       Impact factor: 6.543

Review 2.  Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options.

Authors:  Meysam Yousefi; Tayyeb Bahrami; Arash Salmaninejad; Rahim Nosrati; Parisa Ghaffari; Seyed H Ghaffari
Journal:  Cell Oncol (Dordr)       Date:  2017-09-18       Impact factor: 6.730

Review 3.  Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis.

Authors:  Meysam Yousefi; Rahim Nosrati; Arash Salmaninejad; Sadegh Dehghani; Alireza Shahryari; Alihossein Saberi
Journal:  Cell Oncol (Dordr)       Date:  2018-03-22       Impact factor: 6.730

4.  The Long-Term and Short-Term Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis.

Authors:  Xianjing Chu; Lishui Niu; Gang Xiao; Haiqin Peng; Fuxing Deng; Zhiyuan Liu; Honghua Wu; Lei Yang; Zhuguilong Tan; Zhanzhan Li; Rongrong Zhou
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

Review 5.  Cooperation between Angiogenesis, Vasculogenesis, Chemotaxis, and Coagulation in Breast Cancer Metastases Development: Pathophysiological Point of View.

Authors:  Elżbieta Zarychta; Barbara Ruszkowska-Ciastek
Journal:  Biomedicines       Date:  2022-01-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.